AUTOLUS THERAPEUTICS LTD
AUTL·05280R100·US·ADR·Healthcare - Biotechnology-13D/G
AUTL (AUTOLUS THERAPEUTICS LTD) is held by 44 institutional investors as of Q1 2026. Largest holders: Blackstone Inc. ($28.3M), SCHRODER INVESTMENT MANAGEMENT GROUP ($12.1M), BNP Paribas Asset Management Holding S.A. ($4.6M). Net institutional sentiment: Mixed.
44
Holders
Avg rating(10 Elite)
$65.7M
Total Value
45% (47)
Fund Consensus
17 buying - 21 selling
Who's Trading
ActivistMAMAK Capital Fund LP12.6%May 15, 2026
ActivistARArmistice Capital, LLC5.9%May 15, 2026
ActivistDTDeep Track Capital, LP1.0%Nov 14, 2025
ActivistSPSyncona Portfolio Limited10.8%May 7, 2025
13F: Insider & Congress:
Showing 1-20 of 47
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer